Building Blocks; Molecular Biology; Pharmaceutical/API Drug Impurities/Metabolites;
應用
N-(4-Fluorophenyl)-N′-[4-[(6-hydroxy-7-methoxy-4-quinolinyl)oxy]phenyl]-1,1-cyclopropanedicarboxamide can be useful in the design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitors.
滬ICP備17019645號
400-821-0725
